Sale!

GDF1 Gene Transposition of Great Arteries Dextrolooped 3 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The GDF1 Gene Transposition of Great Arteries Dextrolooped 3 NGS Genetic DNA Test is a specialized genetic analysis that identifies mutations in the GDF1 gene associated with congenital heart defects. This comprehensive test utilizes next-generation sequencing technology to detect abnormalities that cause transposition of the great arteries, a serious cardiac condition where the main blood vessels from the heart are reversed. The test is particularly important for families with a history of congenital heart disease, newborns showing cardiac symptoms, and individuals planning pregnancy with known genetic risks. At only $500 USD, this test provides crucial information for early intervention and personalized treatment planning. Results are typically available within 3-4 weeks from blood, extracted DNA, or FTA card samples.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

GDF1 Gene Transposition of Great Arteries Dextrolooped 3 NGS Genetic DNA Test

Comprehensive Introduction to Cardiac Genetic Testing

The GDF1 Gene Transposition of Great Arteries Dextrolooped 3 NGS Genetic DNA Test represents a breakthrough in pediatric cardiac genetics, offering families and healthcare providers critical insights into congenital heart conditions. This advanced diagnostic tool specifically targets mutations in the GDF1 gene, which plays a vital role in embryonic heart development and proper formation of cardiac structures.

Transposition of the great arteries (TGA) is a serious congenital heart defect where the two main arteries leaving the heart are reversed from their normal positions. The dextrolooped variant represents a specific anatomical configuration that requires precise genetic understanding for optimal clinical management and treatment planning.

What This Advanced Genetic Test Detects

Our NGS-based genetic analysis provides comprehensive detection capabilities:

  • Identifies mutations in the GDF1 gene associated with cardiac malformations
  • Detects specific genetic variants linked to transposition of great arteries
  • Analyzes the dextrolooped anatomical configuration patterns
  • Screens for inherited and de novo genetic abnormalities
  • Provides detailed variant classification and clinical significance assessment

Clinical Indications and Who Should Consider Testing

This genetic test is particularly recommended for:

  • Newborns diagnosed with congenital heart defects
  • Children presenting with cyanosis (bluish skin coloration)
  • Individuals with family history of congenital heart disease
  • Patients with unexplained cardiac abnormalities
  • Couples planning pregnancy with known cardiac genetic risks
  • Individuals with dysmorphic features suggesting genetic syndromes

Significant Benefits of Genetic Testing

Undergoing the GDF1 genetic analysis provides multiple advantages:

  • Early Intervention Planning: Enables timely medical and surgical interventions
  • Family Risk Assessment: Identifies inheritance patterns for genetic counseling
  • Personalized Treatment: Guides customized cardiac care approaches
  • Reproductive Planning: Informs future family planning decisions
  • Comprehensive Diagnosis: Provides definitive genetic confirmation

Understanding Your Genetic Test Results

Our comprehensive genetic report includes detailed interpretation:

  • Positive Result: Indicates presence of GDF1 gene mutation requiring specialized cardiac care
  • Negative Result: Suggests absence of tested mutations but may require additional evaluation
  • Variant of Uncertain Significance: Requires ongoing monitoring and family studies
  • Carrier Status: Identifies individuals who may pass mutations to offspring

All results are accompanied by detailed genetic counseling to ensure complete understanding and appropriate next steps for medical management.

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Technology: Next-Generation Sequencing (NGS)
  • Specialty: Pediatric Genetics
  • Department: Genetics
  • Method: NGS Technology
  • Disease Type: Dysmorphology

Pre-Test Requirements and Preparation

Before testing, we require:

  • Complete clinical history of the patient
  • Genetic counseling session to create detailed family pedigree
  • Documentation of affected family members
  • Informed consent for genetic testing

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified genetic counselors and medical professionals ensures consistent, high-quality care regardless of location.

Take Action for Cardiac Health

Don’t wait to get the answers you need for comprehensive cardiac genetic assessment. Our team of genetic specialists is ready to provide the expert guidance and testing necessary for informed medical decisions.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book the GDF1 Gene Transposition of Great Arteries Dextrolooped 3 NGS Genetic DNA Test. Early detection can make a significant difference in treatment outcomes and quality of life.